Notably, several studies have recently shown that changes in expression of the ClC-3 gene may augment the risk of developing a variety of cancers, including endometrial carcinoma [15], nasopharyngeal carcinoma [16], breast cancer [13] and glioma [17]. Here, CLCN3 is linked to nasopharyngeal carcinoma.